Antibody prevents virus reactivation within the central nervous system

Journal of Immunology

Volumn 162, Issue 12, 1999, Pages 7358-7368

  Lin, Mark T ^a   Hinton, David R ^a   Marten, Norman W ^a   Bergmann, Cornelia C ^a   Stohlman, Stephen A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DEMYELINATION; DISEASE COURSE; ENCEPHALOMYELITIS; GENE DISRUPTION; HUMORAL IMMUNITY; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; VIRUS REACTIVATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; CORONAVIRUS INFECTIONS; CYTOTOXICITY, IMMUNOLOGIC; ENCEPHALOMYELITIS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN M; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MURINE HEPATITIS VIRUS; NEUTRALIZATION TESTS; T-LYMPHOCYTES, CYTOTOXIC; VIRUS ACTIVATION;

EID: 0033564339     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Zinkernagel, R. M. 1996. Immunology taught by viruses. Science 271:173.
2. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
3. Kagi, D., P. Seiler, J. Pavlovic, B. Ledermann, K. Burki, R. M. Zinkernagel, and H. Hengartner. 1995. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur J. Immunol. 25: 3256.
4. Weiner, L. P. 1973. Pathogenesis of demyelination induced by a mouse hepatitis. Arch. Neurol. 28:298.
5. Lampert, P. W., J. K. Sims, and A. J. Kniazeff. 1973. Mechanism of demyelination in JHM virus encephalomyelitis. Acta Neuropathol. 24:76.
6. Lin, M. T., S. A. Stohlman, and D. R. Hinton. 1997. Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis. J. Virol. 71:383.
7. Stohlman, S. A., C. C. Bergmann, R. C. van der Veen, and D. R. Hinton. 1995. Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system. J. Virol. 69: 684.
8. Parra, B., D. R. Hinton, N. W. Marten, C. C. Bergmann, M. T. Lin, C. S. Yang, and S. A. Stohlman. 1998. γ Interferon is required for viral clearance from central nervous system oligodendroglia. J. Immunol. In press.
9. Thomsen, A. R., J. Johansen, O. Marker, and J. P. Christensen. 1996. Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class 11-deficient mice and B cell-deficient mice. J. Immunol. 157:3074.
10. + T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc. Natl. Acad. Sci. USA 94:6874.
11. Mozdzanowska, K., M. Furchner, G. Washko, J. Mozdzanowski, and W. Gerhard. 1997. A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro. J. Virol. 71:4347.
12. + T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 159:105.
13. Amor, S., M. F. Scallan, M. M. Morris, H. Dyson, and J. K. Fazakerley. 1996. Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis. J. Gen. Virol. 77:281.
14. Griffin, D., B. Levine, W. Tyor, S. Ubol, and P. Despres. 1997. The role of antibody in recovery from alphavirus encephalitis. Immunol. Rev. 159:155.
15. Sedgwick, J. D., and R. Dorries. 1991. The immune system response to viral infection of the CNS. Neuroscience 3:93.
16. Joly, E., L. Mucke, and M. B. Oldstone. 1991. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science 253: 1283.
17. Moskophidis, D., M. Battegay, M. van den Broek, E. Laine, U. Hoffmann-Rohrer, and R. M. Zinkernagel. 1995. Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus. J. Gen. Virol. 76:381.
18. Levine, B., J. M. Hardwick, B. D. Trapp, T. O. Crawford, R. C. Bollinger, and D. E. Griffin. 1991. Antibody-mediated clearance of alphavirus infection from neurons. Science 254:856.
19. Fujinami, R. S., and M. B. Oldstone. 1979. Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell. Nature 279:529.
20. Liebert, U. G., S. Schneider-Schaulies, K. Baczko, and V. ter Meulen. 1990. Antibody-induced restriction of viral gene expression in measles encephalitis in rats. J. Virol. 64:706.
21. Levine, B., and D. E. Griffin. 1993. Molecular analysis of neurovirulent strains of Sindbis virus that evolve during persistent infection of seid mice. J. Virol. 67: 6872.
22. Garcia-Blanco, M. A., and B. R. Cullen. 1991. Molecular basis of latency in pathogenic human viruses. Science 254:815.
23. Narayan, O., M. C. Zink, D. Huso, D. Sheffer, S. Crane, S. Kennedy-Stoskopf, P. E. Jolly, and J. E. Clements. 1988. Lentiviruses of animals are biological models of the human immunodeficiency viruses. Microb. Pathog. 5:149.
24. Pewe, L., G. F. Wu, E. M. Barnett, R. F. Castro, and S. Perlman. 1996. Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease. Immunity 5:253.
25. Buchmeier, M. J., H. A. Lewicki, P. J. Talbot, and R. L. Knobler. 1984. Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology 132:261.
26. Nakanaga, K., K. Yamanouchi, and K. Fujiwara. 1986. Protective effect of monoclonal antibodies on lethal mouse hepatitis virus infection in mice. J. Virol. 59: 168.
27. Lecomte, J., V. Cainelli-Gewbara, G. Mercier, S. Mansour, P. J. Talbot, G. Lussier, and D. Oth. 1987. Protection from mouse hepatitis virus type 3-induced acute disease by an anti-nucleoprotein monoclonal antibody. Arch. Virol. 97:123.
28. Fleming, J. O., R. A. Shubin, M. A. Sussman, N. Casteel, and S. A. Stohlman. 1989. Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology 168:162.
29. Yokomori, K., S. C. Baker, S. A. Stohlman, and M. M. C. Lai. 1992. Hemagglutinin-esterase-specific monoclonal antibodies alter the neuropathogenicity of mouse hepatitis virus. J. Virol. 66:2865.
30. Kitamura, D., and K. Rajewsky. 1992. Targeted disruption of μ chain membrane exon causes loss of heavy-chain allelic exclusion. Nature 356:154.
31. Parra, B., D. R. Hinton, M. T. Lin, D. J. Cua, and S. A. Stohlman. 1997. Kinetics of cytokine mRNA expression in the central nervous system following lethal and nonlethal coronavirus-induced acute encephalomyelitis. Virology 233:260.
32. Fleming, J. O., M. Trousdale, F. El-Zaatari, S. A. Stohlman, and L. P. Weiner. 1986. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J. Virol. 58:869.
33. Bergmann, C. C., Q. Yao, M. Lin, and S. A. Stohlman. 1996. The JHM strain of mouse hepatitis virus induces a spike protein-specific Db-restricted cytotoxic T cell response. J. Gen. Virol. 77:315.
34. Fleming, J. O., S. A. Stohlman, R. C. Harmon, M. M. C. Lai, J. A. Frelinger, and L. P. Weiner. 1983. Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology 131:296.
35. Childs, J. C., S. A. Stohlman, L. Kingsford, and R. Russell. 1983. Antigenic relationships of murine coronaviruses. Arch. Virol. 78:81.
36. Chiewsilp, D., and J. M. McCown. 1972. Elimination of repeated clot formation in mouse ascitic fluid containing arbovirus antibodies. Appl. Microbiol. 24:288.
37. Stohlman, S. A., C. C. Bergmann, D. Cua, H. Wege, and R. van der Veen. 1994. Location of antibody epitopes within the mouse hepatitis virus nucleocapsid protein. Virology 202:146.
38. + T cells. J. Immunol. 160:2896.
39. Wang, F. I., J. O. Fleming, and M. M. C. Lai. 1992. Sequence analysis of the spike protein gene of murine coronavirus variants: study of genetic sites affecting neuropathogenicity. Virology 186:742.
40. Stohlman, S. A., S. Kyuwa, J. M. Polo, D. Brady, M. M. C. Lai, and C. C. Bergmann. 1993. Characterization of mouse hepatitis virus-specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain. J. Virol. 67:7050.
41. + T cells is dependent on interferon-γ. Lymphokine Cytokine Res. 10:353.
42. Young, H. A., and K. J. Hardy. 1995. Role of interferon-γ in immune cell regulation. J. Leukocyte Biol. 58:373.
43. + T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. J. Virol. 69:8127.
44. Dethlefs, S., M. Brahic, and E. L. Larsson-Sciard. 1997. An early, abundant cytotoxic T-lymphocyte response against Theiler's virus is critical for preventing viral persistence. J. Virol. 71:8875.
45. Wang, F., D. Hinton, W. Gilmore, M. Trousdale, and J. Fleming. 1992. Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination. Lab. Invest. 66:744.
46. Perlman, S., and D. Ries. 1987. The astrocyte is a target cell in mice persistently infected with mouse hepatitis virus, strain JHM. Microb. Pathog. 3:309.
47. Stohlman, S. A., and L. P. Weiner. 1981. Chronic central nervous system demyelination in mice after JHM virus infection. Neurology 31:38.
48. Lane, T. E., A. D. Paoletti, and M. J. Buchmeier. 1997. Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus. J. Virol. 71:2202.
49. Jonjic, S., I. Pavic, B. Polic, I. Crnkovic, P. Lucin, and U. H. Koszinowski. 1994. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J. Exp. Med. 179:1713.
50. Brundler, M. A., P. Aichele, M. Bachmann, D. Kitamura, K. Rajewsky, and R. M. Zinkernagel. 1996. Immunity to viruses in B cell-deficient mice: influence of antibodies on virus persistence and on T cell memory. Eur. J. Immunol. 26: 2257.
51. Epstein, S. L., C.-Y. Lo, J. A. Misplon, and J. R. Bennink. 1998. Mechanism of protective immunity against influenza virus infection in mice without antibodies. J. Immunol. 160:322.
52. Schwender, S., H. Imrich, and R. Dorries. 1991. The pathogenic role of virus-specific antibody-secreting cells in the central nervous system of rats with different susceptibility to coronavirus-induced demyelinating encephalitis. Immunology 74:533.
53. Stohlman, S. A., and L. P. Weiner. 1978. Stability of neurotropic mouse hepatitis virus (JHM strain) during chronic infection of neuroblastoma cells. Arch. Virol. 57:53.
54. Stohlman, S., A. Sakaguchi, and L. Weiner. 1979. Characterization of the cold-sensitive murine hepatitis virus mutants rescued from latently infected cells by cell fusion. Virology 98:448.
55. O'Rourke, E. J., W. H. Guo, and A. S. Huang. 1983. Antibody-induced modulation of proteins in vesicular stomatitis virus-infected fibroblasts. Mol. Cell. Biol. 3:1580.
56. Roux, L., P. Beffy, and A. Portner. 1984. Restriction of cell surface expression of Sendai virus hemagglutinin-neuraminidase glycoprotein correlates with its higher instability in persistently and standard plus defective interfering virus infected BHK-21 cells. Virology 138:118.
57. + cells: mechanism for persistence in AIDS. Cell 53:483.
58. Oldstone, M. B., and M. J. Buchmeier. 1982. Restricted expression of viral glycoprotein in cells of persistently infected mice. Nature 300:360.
59. Williamson, J. S., K. C. Sykes, and S. A. Stohlman. 1991. Characterization of brain-infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM. J. Neuroimmunol. 32:199.
60. Dorries, R., S. Schwender, H. Imrich, and H. Harms. 1991. Population dynamics of lymphocyte subsets in the central nervous system of rats with different susceptibility to coronavirus-induced demyelinating encephalitis. Immunology 74: 539.
61. Homann, D., A. Tishon, D. P. Berger, W. O. Weigle, M. G. von Herrath, and M. B. A. Oldstone. 1998. Evidence of an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from μMT/μMT mice. J. Virol. 72:9208.
62. Moskophidis, D., F. Lechner, H. Pircher, and R. M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362:758.
63. Moskophidis, D., F. Lechner, H. Hengartner, and R. M. Zinkernagel. 1994. MHC class I and non-MHC-linked capacity for generating an anti-viral CTL response determines susceptibility to CTL exhaustion and establishment of virus persistence in mice. J. Immunol. 152:4976.
64. Castro, R. F., and S. Perlman. 1996. Differential antigen recognition by T cells from the spleen and central nervous system of coronavirus-infected mice. Virology 222:247.